Zhejiang Orient Gene Biotech Co., Ltd. Class ASSE: 688298

Announcement on SSE’s Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report

· Issued by Zhejiang Orient Gene Biotech Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on SSE’s Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis

Earlier from Zhejiang Orient Gene Biotech Co., Ltd. Class A

All Zhejiang Orient Gene Biotech Co., Ltd. Class A news releases